It is believed the lenacapavir shot could end HIV/Aids in the country within 14 to 18 years if enough people were to take it.

By William Baloyi When President Donald Trump issued an executive order suspending all foreign aid to South Africa, in ...

Through a US$ 29 million grant, South Africa will receive enough medicine to provide HIV prevention to 450 000 people at high ...

South Africa has become the first African country to register lenacapavir, a groundbreaking six-monthly HIV prevention ...

The timing of the renewed support is pivotal. South Africa is preparing to roll out Lenacapavir, a groundbreaking long-acting antiretroviral treatment, as early as March or April 2026.

The initial supply in South Africa is set to begin in April 2026, funded by a $29.2 million Global Fund grant with an additional $5 million allocated by the Networking HIV and AIDS Community of ...

South Africa has become the first African country, and our medicines regulator the third worldwide, to register the ...

Lenacapavir is a revolutionary long-acting injectable drug that offers six months of protection with just two annual ...

South Africa has become the first African country — and our medicines regulator the third worldwide — to register the ...

One in ten clinics in South Africa — across 22 health districts in six provinces — will start to hand out a twice-a-year anti ...

South Africa on Thursday welcomed a U.S. bridging plan worth $115 million that would continue funding HIV treatment and prevention programs until the end of March, saying it was a sign of good ...

Doctoral Researcher, School of Public Health and Public Health Technical Advisor, Anova Health Institute, University of the Witwatersrand Around 8.45 million people in South Africa live with HIV – an ...